vs
Axsome Therapeutics, Inc.（AXSM）与PREFORMED LINE PRODUCTS CO（PLPC）财务数据对比。点击上方公司名可切换其他公司
Axsome Therapeutics, Inc.的季度营收约是PREFORMED LINE PRODUCTS CO的1.1倍（$191.2M vs $173.1M），Axsome Therapeutics, Inc.同比增速更快（57.4% vs 3.6%），过去两年Axsome Therapeutics, Inc.的营收复合增速更高（48.1% vs 10.8%）
Jazz Pharmaceuticals是一家全球生物制药企业，专注于肿瘤学与神经科学领域的药物研发及商业化。公司2003年在美国加利福尼亚州成立，目前总部位于爱尔兰都柏林，业务覆盖全球多个核心市场。
预成型线路产品公司（PLPC）研发、生产和销售适用于输配电、通信及可再生能源基建领域的工程硬件组件，服务全球多地的公用事业、网络运营商及工业客户，提供可提升网络可靠性与运营效率的解决方案。
AXSM vs PLPC — 直观对比
营收规模更大
AXSM
是对方的1.1倍
$173.1M
营收增速更快
AXSM
高出53.8%
3.6%
两年增速更快
AXSM
近两年复合增速
10.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $191.2M | $173.1M |
| 净利润 | — | $8.4M |
| 毛利率 | — | 29.8% |
| 营业利润率 | -33.1% | 6.8% |
| 净利率 | — | 4.9% |
| 营收同比 | 57.4% | 3.6% |
| 净利润同比 | — | -19.3% |
| 每股收益（稀释后） | — | $1.72 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXSMPLPC
| Q1 26 | $191.2M | — | ||
| Q4 25 | $196.0M | $173.1M | ||
| Q3 25 | $171.0M | $178.1M | ||
| Q2 25 | $150.0M | $169.6M | ||
| Q1 25 | $121.5M | $148.5M | ||
| Q4 24 | $118.8M | $167.1M | ||
| Q3 24 | $104.8M | $147.0M | ||
| Q2 24 | $87.2M | $138.7M |
净利润AXSMPLPC
| Q1 26 | — | — | ||
| Q4 25 | $-28.6M | $8.4M | ||
| Q3 25 | $-47.2M | $2.6M | ||
| Q2 25 | $-48.0M | $12.7M | ||
| Q1 25 | $-59.4M | $11.5M | ||
| Q4 24 | $-74.9M | $10.5M | ||
| Q3 24 | $-64.6M | $7.7M | ||
| Q2 24 | $-79.3M | $9.4M |
毛利率AXSMPLPC
| Q1 26 | — | — | ||
| Q4 25 | — | 29.8% | ||
| Q3 25 | — | 29.7% | ||
| Q2 25 | — | 32.7% | ||
| Q1 25 | — | 32.8% | ||
| Q4 24 | — | 33.3% | ||
| Q3 24 | — | 31.1% | ||
| Q2 24 | — | 31.9% |
营业利润率AXSMPLPC
| Q1 26 | -33.1% | — | ||
| Q4 25 | -13.8% | 6.8% | ||
| Q3 25 | -27.0% | 7.4% | ||
| Q2 25 | -24.5% | 10.1% | ||
| Q1 25 | -46.9% | 8.8% | ||
| Q4 24 | -61.1% | 10.5% | ||
| Q3 24 | -59.8% | 7.1% | ||
| Q2 24 | -89.5% | 8.1% |
净利率AXSMPLPC
| Q1 26 | — | — | ||
| Q4 25 | -14.6% | 4.9% | ||
| Q3 25 | -27.6% | 1.5% | ||
| Q2 25 | -32.0% | 7.5% | ||
| Q1 25 | -48.9% | 7.8% | ||
| Q4 24 | -63.1% | 6.3% | ||
| Q3 24 | -61.7% | 5.2% | ||
| Q2 24 | -91.0% | 6.8% |
每股收益（稀释后）AXSMPLPC
| Q1 26 | — | — | ||
| Q4 25 | $-0.55 | $1.72 | ||
| Q3 25 | $-0.94 | $0.53 | ||
| Q2 25 | $-0.97 | $2.56 | ||
| Q1 25 | $-1.22 | $2.33 | ||
| Q4 24 | $-1.54 | $2.13 | ||
| Q3 24 | $-1.34 | $1.54 | ||
| Q2 24 | $-1.67 | $1.89 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $305.1M | — |
| 总债务越低越好 | $70.0M | $38.3M |
| 股东权益账面价值 | — | $475.5M |
| 总资产 | $713.6M | $653.6M |
| 负债/权益比越低杠杆越低 | — | 0.08× |
8季度趋势，按日历期对齐
现金及短期投资AXSMPLPC
| Q1 26 | $305.1M | — | ||
| Q4 25 | $322.9M | — | ||
| Q3 25 | $325.3M | — | ||
| Q2 25 | $303.0M | — | ||
| Q1 25 | $300.9M | — | ||
| Q4 24 | $315.4M | — | ||
| Q3 24 | $327.3M | — | ||
| Q2 24 | $315.7M | — |
总债务AXSMPLPC
| Q1 26 | $70.0M | — | ||
| Q4 25 | — | $38.3M | ||
| Q3 25 | — | $36.0M | ||
| Q2 25 | — | $31.8M | ||
| Q1 25 | — | $29.1M | ||
| Q4 24 | — | $20.8M | ||
| Q3 24 | — | $27.2M | ||
| Q2 24 | — | $31.6M |
股东权益AXSMPLPC
| Q1 26 | — | — | ||
| Q4 25 | $88.3M | $475.5M | ||
| Q3 25 | $73.7M | $466.3M | ||
| Q2 25 | $73.1M | $460.7M | ||
| Q1 25 | $53.2M | $435.8M | ||
| Q4 24 | $57.0M | $422.3M | ||
| Q3 24 | $92.9M | $429.0M | ||
| Q2 24 | $102.9M | $416.2M |
总资产AXSMPLPC
| Q1 26 | $713.6M | — | ||
| Q4 25 | $689.8M | $653.6M | ||
| Q3 25 | $669.3M | $644.6M | ||
| Q2 25 | $639.8M | $631.5M | ||
| Q1 25 | $596.7M | $592.5M | ||
| Q4 24 | $568.5M | $573.9M | ||
| Q3 24 | $561.5M | $592.0M | ||
| Q2 24 | $548.2M | $572.6M |
负债/权益比AXSMPLPC
| Q1 26 | — | — | ||
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.08× | ||
| Q2 25 | — | 0.07× | ||
| Q1 25 | — | 0.07× | ||
| Q4 24 | — | 0.05× | ||
| Q3 24 | — | 0.06× | ||
| Q2 24 | — | 0.08× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $21.9M |
| 自由现金流经营现金流 - 资本支出 | — | $11.8M |
| 自由现金流率自由现金流/营收 | — | 6.8% |
| 资本支出强度资本支出/营收 | — | 5.9% |
| 现金转化率经营现金流/净利润 | — | 2.60× |
| 过去12个月自由现金流最近4个季度 | — | $33.3M |
8季度趋势，按日历期对齐
经营现金流AXSMPLPC
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | $21.9M | ||
| Q3 25 | $1.0M | $18.9M | ||
| Q2 25 | $-32.4M | $26.9M | ||
| Q1 25 | $-43.4M | $5.7M | ||
| Q4 24 | $-26.2M | $24.1M | ||
| Q3 24 | $-18.6M | $9.4M | ||
| Q2 24 | $-30.1M | $28.3M |
自由现金流AXSMPLPC
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | $11.8M | ||
| Q3 25 | $988.0K | $8.3M | ||
| Q2 25 | $-32.4M | $18.6M | ||
| Q1 25 | $-43.7M | $-5.3M | ||
| Q4 24 | $-26.2M | $20.6M | ||
| Q3 24 | $-18.7M | $5.8M | ||
| Q2 24 | $-30.2M | $24.6M |
自由现金流率AXSMPLPC
| Q1 26 | — | — | ||
| Q4 25 | -9.6% | 6.8% | ||
| Q3 25 | 0.6% | 4.7% | ||
| Q2 25 | -21.6% | 10.9% | ||
| Q1 25 | -36.0% | -3.6% | ||
| Q4 24 | -22.1% | 12.3% | ||
| Q3 24 | -17.9% | 3.9% | ||
| Q2 24 | -34.6% | 17.7% |
资本支出强度AXSMPLPC
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 5.9% | ||
| Q3 25 | 0.0% | 6.0% | ||
| Q2 25 | 0.0% | 4.9% | ||
| Q1 25 | 0.3% | 7.4% | ||
| Q4 24 | 0.0% | 2.1% | ||
| Q3 24 | 0.1% | 2.4% | ||
| Q2 24 | 0.1% | 2.7% |
现金转化率AXSMPLPC
| Q1 26 | — | — | ||
| Q4 25 | — | 2.60× | ||
| Q3 25 | — | 7.21× | ||
| Q2 25 | — | 2.12× | ||
| Q1 25 | — | 0.49× | ||
| Q4 24 | — | 2.30× | ||
| Q3 24 | — | 1.22× | ||
| Q2 24 | — | 3.02× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXSM
| Product sales, net | $189.4M | 99% |
| Royalty revenue and milestone revenue | $1.8M | 1% |
PLPC
暂无分部数据
